399 related articles for article (PubMed ID: 21450098)
1. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M; Laird-Offringa IA
Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
[TBL] [Abstract][Full Text] [Related]
2. Immune response in lung cancer mouse model mimics human anti-Hu reactivity.
Kazarian M; Calbo J; Proost N; Carpenter CL; Berns A; Laird-Offringa IA
J Neuroimmunol; 2009 Dec; 217(1-2):38-45. PubMed ID: 19765830
[TBL] [Abstract][Full Text] [Related]
3. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
4. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
6. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
7. Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.
Pulido MA; DerHartunian MK; Qin Z; Chung EM; Kang DS; Woodham AW; Tsou JA; Klooster R; Akbari O; Wang L; Kast WM; Liu SV; Verschuuren JJGM; Aswad DW; Laird-Offringa IA
J Neuroimmunol; 2016 Oct; 299():70-78. PubMed ID: 27725125
[TBL] [Abstract][Full Text] [Related]
8. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
[TBL] [Abstract][Full Text] [Related]
10. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
[TBL] [Abstract][Full Text] [Related]
12. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
13. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
14. Anti-Hu Positive Antibodies and Small Cell Carcinoma: A Single Center Review.
List M; Jamous F; Gupta A; Huntington M
S D Med; 2015 Jun; 68(6):251, 253-5. PubMed ID: 26137725
[TBL] [Abstract][Full Text] [Related]
15. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
16. A new hope: the immunotherapy in small cell lung cancer.
Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
18. What Are the Biomarkers for Immunotherapy in SCLC?
Longo V; Catino A; Montrone M; Pizzutilo P; Annese T; Pesola F; Marech I; Cassiano S; Ribatti D; Galetta D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681779
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.
Anderson NE; Rosenblum MK; Graus F; Wiley RG; Posner JB
Neurology; 1988 Sep; 38(9):1391-8. PubMed ID: 2842702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]